Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia

Published:2014-02 Issue:2 Volume:42 Page:126-136.e1
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Maffei Rossana,Fiorcari Stefania,Bulgarelli Jenny,Rizzotto Lara,Martinelli Silvia,Rigolin Gian Matteo,Debbia Giulia,Castelli Ilaria,Bonacorsi Goretta,Santachiara Rita,Forconi Francesco,Rossi Davide,Laurenti Luca,Palumbo Giuseppe A.,Vallisa Daniele,Cuneo Antonio,Gaidano Gianluca,Luppi Mario,Marasca Roberto

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference50 articles.

1. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance;Meads;Clin Cancer Res,2008

2. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1;Burger;Blood,2000

3. Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression;Ding;Br J Haematol,2009

4. Physical contact with endothelial cells through beta1- and beta2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells;Maffei;Haematologica,2012

5. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1;Pedersen;Blood,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review;Advances in Hematology;2024-01

2. Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms;Frontiers in Immunology;2022-10-12

3. Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma;Blood Advances;2022-02-14

4. Role of Endothelial Cells in Hematological Malignancies;Eurasian Journal of Medicine and Oncology;2022

5. Immunomodulatory Drugs for the Treatment of B Cell Malignancies;International Journal of Molecular Sciences;2021-08-09